VIZZ & Qlosi Eye Drops for Presbyopia: How They Work, Side Effects, Cost, and Who They're For (2026)
If you've started holding your phone further away to read it, enlarging the font on everything, or finding yourself squinting under restaurant lighting — your eye muscles are telling you something. It's called presbyopia, and it happens to everyone eventually. What most people don't know is that reading glasses aren't the only option anymore. Here's what VIZZ and Qlosi eye drops actually do, who they work best for, and what you should realistically expect.
What Is Presbyopia — and Why Does It Start in Your 40s?
Inside your eyes are small focusing muscles. The closer or smaller something is, the harder those muscles have to work to bring it into focus. Like any muscle in the body, they weaken over time. By our early 40s — and sometimes as early as the mid-to-late 30s for people with heavy screen demands — that weakening becomes noticeable. You need your arm to be longer. You're taking photos of small print and zooming in on your phone. You're straining in low light. This is presbyopia, from the Greek for "aging eyes," and it's a completely normal part of how eyes change with age.
One group that tends to feel this the most is people who've been farsighted their whole lives. Farsighted patients often sail through their first few decades with no need for glasses at all — sometimes never having had an eye exam — and then hit their early 40s and suddenly find they can't function without correction. For someone who's never worn glasses, that transition can be jarring. These patients often don't know presbyopia drops exist, and for them in particular, VIZZ and Qlosi can be a meaningful discovery.
How VIZZ and Qlosi Actually Work
Reading glasses correct presbyopia by acting as magnifying glasses — they make images physically larger and do the focusing work that your eye muscles can no longer do on their own.
VIZZ and Qlosi work differently. Rather than magnifying anything, they temporarily change the physiology of the eye itself. Both drops work by inducing pupillary miosis — making the pupil smaller. A smaller pupil creates what's known as a "pinhole effect," the same reason squinting helps you see more clearly. By restricting the entry of stray light and allowing only perpendicular light rays to reach the retina, the eye's optical system becomes more precise — and near vision improves without any magnification at all.
A single dose can provide up to 12 hours of improved near vision. Patients are generally advised to use the drops about 30 minutes before they need clearer near vision — before a dinner out, a work meeting with small print, or any task where reading glasses would otherwise be the default.
VIZZ vs. Qlosi: What's the Difference?
Both drops share the same fundamental goal — improving near vision through pupillary miosis — but they use different active ingredients and mechanisms to get there.
It helps to understand the generational context. The first generation of presbyopia drops, Vuity, established the concept but came with a noticeable side effect burden. VIZZ is second-generation, with a meaningfully improved side effect profile. Qlosi is third-generation, refining the formula further. A fourth-generation drop is currently in development. Each successive generation has brought the side effects down while maintaining or improving efficacy.
In clinical practice, the differences are subtle for most patients. VIZZ can cause temporary eye redness during the first week of use in roughly 10 to 15% of patients — this resolves on its own as the eye adjusts. Qlosi does not carry the same redness profile. Both drops carry a rare theoretical risk of retinal complications, which is why a full retinal health evaluation — including imaging — is recommended before either is prescribed. This isn't a barrier to getting them, but it is the reason they require a prescription and an exam, not a walk-in pharmacy purchase.
Both VIZZ and Qlosi are dispensed through a mail-order specialty pharmacy, Blink Rx, and need to be kept refrigerated. They are preservative-free. Once prescribed, the process is straightforward: the prescription is sent to the pharmacy, they contact the patient directly, and the drops are shipped to the patient's home.
Who Is a Good Candidate?
The sweet spot for these drops is patients between roughly 40 and 55 who are noticing early presbyopia and want flexibility beyond reading glasses — particularly patients who don't want to wear glasses at all, or whose bifocal glasses or contact lenses aren't delivering the near clarity they're looking for. Bifocal contact lenses, for all their convenience, are not always known for sharp near vision, and presbyopia drops can meaningfully supplement that.
Patients with very high prescriptions or more advanced presbyopia — generally those over 65 — may find the results less pronounced, because the degree of correction these drops can provide has limits. That doesn't mean they can't be useful in some cases, but realistic expectations are important.
What to Actually Expect: Realistic Outcomes
These drops are best understood as an adjunctive treatment — a tool that enhances near vision and adds flexibility, not a wholesale replacement for optical correction. The goal isn't to simulate perfect unaided vision. The goal is to reduce how often you reach for glasses and expand what you can do comfortably without them.
Consistency in the first week matters. Both VIZZ and Qlosi build in effectiveness with daily use — the effects improve each day and any initial side effects tend to diminish. Patients who try the drops once or twice and give up before the first week aren't getting an accurate picture of what the drops can do. After that initial period, they can be used daily or as needed depending on the patient's lifestyle and preferences.
A useful way to think about it: going out for dinner, at a meeting, on a date — drops. Watching television for hours on a Saturday — glasses. Each has its place, and the flexibility to switch between them is part of the value.
Side effects to know about: temporary redness with VIZZ in the first week for some patients, mild headaches as the eye adjusts (which tend to decrease with each generation of drops), and a very mild dimming of vision in rare cases due to the pupil constriction. None of these are common at the level seen with first-generation drops, and most patients find them manageable.
Cost and Insurance
Neither VIZZ nor Qlosi is covered by vision insurance — both are considered elective treatments. Cost runs approximately $180 for a three-month supply of VIZZ and approximately $100 for a two-month supply of Qlosi, making Qlosi modestly more affordable for ongoing use.
Whether a patient uses the drops daily or occasionally significantly affects the real-world cost. For someone using them situationally rather than every day, a supply stretches considerably further than the base pricing suggests.
Where These Drops Fit Alongside Other Options
Presbyopia drops work alongside glasses, bifocal contact lenses, progressive lenses, and surgical options — they don't compete with them. Most patients who use VIZZ or Qlosi continue wearing their correction as needed and reach for the drops in situations where glasses aren't practical or desirable.
For patients using bifocal contact lenses who are frustrated by inconsistent near clarity, drops can fill in the gaps that the lenses don't fully cover. For patients who've had bifocal lens implants and still notice limitations in certain lighting conditions, the same logic applies.
The presbyopia drop space is also moving quickly. With a fourth-generation product in development, the efficacy and side effect profile of these drops will continue to improve. What's available now is already meaningfully better than what was available two or three years ago.
Frequently Asked Questions
What are VIZZ and Qlosi eye drops? VIZZ and Qlosi are prescription eye drops that temporarily improve near vision in people with presbyopia. They work by making the pupil smaller, which increases optical precision for close tasks — an effect that can last up to 12 hours per dose.
Do VIZZ or Qlosi require a prescription? Yes. Both require a prescription from an eye doctor. A full eye health evaluation — including retinal imaging — is also recommended before either is prescribed, as a precautionary measure given how the drops work.
What's the difference between VIZZ and Qlosi? Both improve near vision through pupillary miosis but use different active ingredients. VIZZ is second-generation and can cause temporary eye redness in some patients during the first week. Qlosi is third-generation with a refined formulation and does not carry the same redness profile. Both are more effective and better tolerated than the first-generation drop, Vuity.
How long do presbyopia eye drops last? Studies show up to 12 hours of improved near vision per dose. Effects build with consistent daily use over the first week — patients are encouraged to use the drops daily for at least seven days before evaluating effectiveness.
Where can I buy VIZZ or Qlosi? Neither is available at standard retail pharmacies. Both are dispensed through Blink Rx, a mail-order specialty pharmacy. After a prescription is sent, the pharmacy contacts the patient directly and ships the drops to their home. Both need to be refrigerated.
How much do VIZZ and Qlosi cost? VIZZ runs approximately $180 for a three-month supply. Qlosi runs approximately $100 for a two-month supply. Neither is covered by vision insurance.
Can presbyopia drops replace reading glasses? Not entirely — they're best understood as a complement to existing correction rather than a full replacement. They reduce how often glasses are needed and add flexibility for situations where wearing glasses isn't practical, but they work best alongside — not instead of — optical correction.
Are there side effects? The most common are temporary redness with VIZZ in the first week of use, mild headaches as the eye adjusts, and a rare, mild dimming of vision. Side effects have decreased significantly with each generation of drops and are generally manageable for most patients.
If you're in your 40s and noticing your near vision changing — or if you're already wearing bifocals but still frustrated with clarity for close work — VIZZ and Qlosi may be worth a conversation at your next exam.
Schedule your eye exam today!
Dr. Jordan Jin
Vision Care Center
14700 NE 8th St, Ste 105
Bellevue, WA 98007
📞 (425) 746-2122